Hosted on MSN6d
JMP Securities Downgrades MacroGenics (MGNX)
Fintel reports that on November 7, 2024, JMP Securities downgraded their outlook for MacroGenics (NasdaqGS:MGNX) from Market ...
Sachem Capital (SACH) Gets a Hold from JMP Securities
In a report released today, Chris Muller from JMP Securities reiterated a Hold rating on Sachem Capital (SACH – Research Report). The ...
JMP Securities Remains a Buy on Similarweb (SMWB)
JMP Securities analyst Patrick Walravens maintained a Buy rating on Similarweb (SMWB – Research Report) today and set a price target of ...
ETF Daily News5d
JMP Securities Increases Arbutus Biopharma (NASDAQ:ABUS) Price Target to $5.00
Arbutus Biopharma (NASDAQ:ABUS – Free Report) had its price target lifted by JMP Securities to $5.00 in a report published on Wednesday,Stock Target Advisor reports. JMP Securities currently has a buy ...
Nasdaq6d
Evolent Health price target lowered to $27 from $43 at JMP Securities
JMP Securities analyst Constantine Davides lowered the firm’s price target on Evolent Health (EVH) to $27 from $43 and keeps a Market Perform rating on the shares following Q3 results.
Nasdaq6d
AMN Healthcare price target lowered to $47 from $57 at JMP Securities
JMP Securities analyst Constantine Davides lowered the firm’s price target on AMN Healthcare (AMN) to $47 from $57 and keeps an Outperform rating on the shares following Q3 results. Unfulfilled ...
How Reddit went mainstream
Reddit's ability to ensure more human conversation has broadened its appeal and helped it become a place for people not ...
Business Insider3d
Citadel Securities hires 20-year Microsoft vet in a new tech leadership role
An icon in the shape of a lightning bolt. Impact Link Citadel Securities just hired a 20-year Microsoft veteran who will be tasked with helping developers master a crucial and complex coding ...